Anti-tumour necrosis factor (TNF) α treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13PITTONI, V; BOMBARDIERI, M; SPINELLI, F. R et al.Annals of the rheumatic diseases. 2002, Vol 61, Num 8, pp 723-725, issn 0003-4967Article

Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndromeBARONE, F; BOMBARDIERI, M; MANZO, A et al.Arthritis and rheumatism. 2005, Vol 52, Num 6, pp 1773-1784, issn 0004-3591, 12 p.Article

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvementALESSANDRI, C; BOMBARDIERI, M; PAPA, N et al.Annals of the rheumatic diseases. 2004, Vol 63, Num 10, pp 1218-1221, issn 0003-4967, 4 p.Article

Involvement of Autoimmunity in the Pathogenesis of Aggressive PeriodontitisHENDLER, A; MULLI, T. K; HUGHES, F. J et al.Journal of dental research. 2010, Vol 89, Num 12, pp 1389-1394, issn 0022-0345, 6 p.Article

Lymph node IL-18 expression in adult-onset Still's diseaseCONIGLIARO, P; PRIORI, R; BOMBARDIERI, M et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 3, pp 442-443, issn 0003-4967, 2 p.Article

Nucleosome accumulation and reduction of C-reactive protein are associated with the generation of anti-nuclear antibodies in patients with rheumatoid arthritis treated with adalimumab, but not with etanerceptPRIORI, R; ALESSANDRI, C; MAGRINI, L et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 9, pp 1518-1520, issn 0003-4967, 3 p.Article